Cargando…

Bullous drug eruption with low dose methotrexate

Detalles Bibliográficos
Autor principal:	Yuce Inel, Tuba
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Health Directorate of Istanbul 2021
Materias:	Original Article - Rheumatology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848487/ https://www.ncbi.nlm.nih.gov/pubmed/35284795 http://dx.doi.org/10.14744/nci.2020.83798

Ejemplares similares

Sacroiliac joint involvement in ochronotic arthropathy
por: Yüce İnel, Tuba, et al.
Publicado: (2021)

Effects of temporarily suspending low-dose methotrexate treatment for 2 weeks after SARS-CoV-2 vaccine booster on vaccine response in immunosuppressed adults with inflammatory conditions: protocol for a multicentre randomised controlled trial and nested mechanistic substudy (Vaccine Response On/Off Methotrexate (VROOM) study)
por: Abhishek, Abhishek, et al.
Publicado: (2022)

Safety Profile of Methotrexate Therapy in Patients With Rheumatoid Arthritis
por: Mustafa, Syed Hassan, et al.
Publicado: (2022)

Methotrexate Failure in the Treatment of Adult-Onset Still’s Disease: A Case Report
por: Tavakolian, Kameron, et al.
Publicado: (2022)

Patients’ adherence-related beliefs about methotrexate: a qualitative study of the role of written patient information
por: Hayden, Charlotte, et al.
Publicado: (2015)

Effects of Long-Term Methotrexate, Infliximab, and Tocilizumab Administration on Bone Microarchitecture and Tendon Morphology in Healthy Wistar Rats
por: Poutoglidou, Frideriki, et al.
Publicado: (2021)

Is incident rheumatoid arthritis interstitial lung disease associated with methotrexate treatment? Results from a multivariate analysis in the ERAS and ERAN inception cohorts
por: Kiely, Patrick, et al.
Publicado: (2019)

Retrospective analysis of low-dose interleukin-2 therapy on chronic autoimmune thyroid disease with concurrent systemic lupus erythematosus
por: Wang, Naidi, et al.
Publicado: (2023)

Low-dose glucocorticoids plus rituximab versus high-dose glucocorticoids plus rituximab for remission induction in ANCA-associated vasculitis (LoVAS): protocol for a multicentre, open-label, randomised controlled trial
por: Furuta, Shunsuke, et al.
Publicado: (2017)

Acute Vesico-Bullous Eruption from Methotrexate Overdose in a Psoriasis Patient
por: Kim, Hee Joo, et al.
Publicado: (2012)

Low-dose prednisolone treatment of early rheumatoid arthritis and late cardiovascular outcome and survival: 10-year follow-up of a 2-year randomised trial
por: Ajeganova, Sofia, et al.
Publicado: (2014)

Low-dose RaDiation therapy for patients with KNee osteoArthritis (LoRD-KNeA): a protocol for a sham-controlled randomised trial
por: Kim, Byoung Hyuck, et al.
Publicado: (2023)

A long-term, observational cohort study on the safety of low-dose glucocorticoids in ankylosing spondylitis: adverse events and effects on bone mineral density, blood lipid and glucose levels and body mass index
por: Zhang, Yu-Ping, et al.
Publicado: (2015)

Study protocol for a randomised, double-blinded, placebo-controlled phase III trial examining the add-on efficacy, cost–utility and neurobiological effects of low-dose naltrexone (LDN) in patients with fibromyalgia (INNOVA study)
por: Colomer-Carbonell, Ariadna, et al.
Publicado: (2022)

Dosage reduction and discontinuation of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: protocol for a pragmatic, randomised controlled trial (the BIOlogical Dose OPTimisation (BIODOPT) trial)
por: Uhrenholt, Line, et al.
Publicado: (2019)

Azithromycin induced bullous fixed drug eruption
por: Das, Anupam, et al.
Publicado: (2016)

Cyclosporine in Generalized Bullous-Fixed Drug Eruption
por: Beniwal, Ranjana, et al.
Publicado: (2018)

Loxoprofen‐induced bullous fixed drug eruption
por: Yamada, Takayuki, et al.
Publicado: (2019)

Nicotine-induced bullous fixed drug eruption
por: Sargent, Brynn, et al.
Publicado: (2022)

Design of a phase IV randomised, double-blind, placebo-controlled trial assessing the ImPact of Residual Inflammation Detected via Imaging TEchniques, Drug Levels and Patient Characteristics on the Outcome of Dose TaperIng of Adalimumab in Clinical Remission Rheumatoid ArThritis (RA) patients (PREDICTRA)
por: Emery, Paul, et al.
Publicado: (2018)

Distinct Effects of Methotrexate and Etanercept on the B Cell Compartment in Patients With Juvenile Idiopathic Arthritis
por: Glaesener, Stephanie, et al.
Publicado: (2014)

Long-term outcomes in patients with polyarticular juvenile idiopathic arthritis receiving adalimumab with or without methotrexate
por: Lovell, Daniel J, et al.
Publicado: (2020)

Suspected Ticagrelor-Induced Bullous Fixed Drug Eruption
por: Kawall, Tiffany, et al.
Publicado: (2021)

mrna-1273: Bullous drug eruption: case report
Publicado: (2021)

MULTIFOCAL BULLOUS FIXED DRUG ERUPTION DUE TO FLUCONAZOLE
por: Nath, Amiya Kumar, et al.
Publicado: (2008)

Bullous Fixed Drug Eruption Probably Induced by Paracetamol
por: Agarwala, Manoj Kumar, et al.
Publicado: (2016)

Doxycycline Induced Generalized Bullous Fixed Drug Eruption
por: Podder, Indrashis, et al.
Publicado: (2016)

Generalized Bullous Drug Eruption to Faropenem - Hitherto Unreported
por: Gangopadhyay, Anusree, et al.
Publicado: (2017)

Bullous Fixed Drug Eruption Following Ibuprofen Ingestion
por: Fazeli, Seyed Amirhossein, et al.
Publicado: (2018)

Adherence and dosing interval of subcutaneous antitumour necrosis factor biologics among patients with inflammatory arthritis: analysis from a Canadian administrative database
por: Bhoi, Peter, et al.
Publicado: (2017)

Rapid Assessment of Physical Activity and its Association Among Patients with Low Back Pain
por: Azfar, Syed Muhammad, et al.
Publicado: (2019)

Evaluation of Access Disparities to Biologic Disease-Modifying Antirheumatic Drugs in Rural and Urban Communities
por: Peterman, Nicholas J, et al.
Publicado: (2022)

Relapse in rheumatoid arthritis patients undergoing dose reduction and withdrawal of biologics: are predictable factors more relevant than predictive parameters? An observational prospective real-life study
por: Vittecoq, Olivier, et al.
Publicado: (2019)

Disabling chronic low back pain as an iatrogenic disorder: a qualitative study in Aboriginal Australians
por: Lin, Ivan B, et al.
Publicado: (2013)

The use of glucosamine for chronic low back pain: a systematic review of randomised control trials
por: Sodha, Reena, et al.
Publicado: (2013)

Global prevalence of hospital admissions for low back pain: a systematic review with meta-analysis
por: Melman, Alla, et al.
Publicado: (2023)

Allopurinol-Induced Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome: A Cause of Acalculous Cholecystitis?
por: Waseem, Husnain, et al.
Publicado: (2017)

Case Report: Drug-induced Leukocytoclastic Vasculitis in a Patient with Classic Ehlers-Danlos Syndrome
por: Bourji, Khalil, et al.
Publicado: (2019)

Dose–response associations between metabolic indexes and the risk of comorbid type 2 diabetes mellitus among rheumatoid arthritis patients from Northern China: a case–control study
por: Li, Guangxiao, et al.
Publicado: (2019)

Trajectory of intensive treat-to-target disease modifying drug regimen in an observational study of an early rheumatoid arthritis cohort
por: White, Douglas, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_76sttjp8e3ppsqupdlvfq4v0ck